The Efficacy Of Kharjuradi Avaleha In The Management Of Tamaka Shwasa (Bronchial Asthma) In Children - An Open Label Randomized Controlled Clinical Trial

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年5月30日

试验速览

暂无简介。

•Patients of either gender suffering from Tamaka Shwasa (having more than one of these features Shwasakashtata (Breathelessness),
•Kasa (Cough),Ghurghuram (Wheezing) and Parshvashoola (Chest tightness)between age group of 5 to 16 years will be included in the study.
•Patients with history of at least three episodes of Asthma symptoms during previous year.
•Patients who are willing and will give their consent to participate in study.

•Patients below 5 years and above 16 years of age.
•Patients suffering from other chronic lung diseases (other than asthma) such as cystic fibrosis, COPD or bronchiectasis,
•Patients with severe bronchial asthma with prolonged remissions (lasting more than a month).
•Patients with clinically significant cardiovascular disorders, other infectious diseases, with clinically significant cardiovascular, renal, liver, neurological, hematological, endocrinal, infectious, disorders or chronic respiratory disease other than asthma.
•Patients who will not be willing to comply with protocol requirements will be excluded from the study.

发起方